Clonal Evolution and Somatic Reversion in Genetic Predisposition to TP53-Mutated MDS
Original lecture date: February 17, 2022
![Akiko Shimamura portrait](/content/sites/www/en_US/home/education-training/advanced-training/seminars-symposia/science-of-childhood-cancer-series/science-of-childhood-cancer-akiko-shimamura-lecture1/jcr:content/par-1/cnt_row_1275792624/par-1/cnt_column_copy_4413/par-1/cnt_image.img.16.medium.jpg/1645219233069.jpg)
Akiko Shimamura, MD, PhD
Professor of Pediatrics, Harvard Medical School
Samuel E. Lux IV Chair in Hematology Oncology
Director, Bone Marrow Failure and MDS Program
Dana Farber/Boston Children’s Cancer and Blood Disorders Center